Oncolytics Biotech Inc (ONCY): 12 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Mar 13, 2026 | Kelly Jared Director, Officer | 5,050 | $0.96 | $4.8K | no history |
| Mar 13, 2026 | Parsons James T. Director | 10,000 | $1.03 | $10.3K | no history |
| Feb 13, 2026 | Andrews Patricia S Director | 35,400 | $0.86 | $30.4K | no history |
| Feb 13, 2026 | Kelly Jared Director, Officer | 35,100 | $0.84 | $29.5K | no history |
| Feb 13, 2026 | Hagerman Allison Officer | 10,000 | $0.83 | $8.3K | no history |
| Feb 13, 2026 | Aromando Andrew Officer | 29,600 | $0.86 | $25.5K | no history |
| Feb 13, 2026 | Seizinger Bernd R. Director | 100,000 | $0.84 | $83.8K | no history |
| Feb 13, 2026 | Brown Deborah Margaret Director | 25,000 | $0.85 | $21.2K | no history |
| Feb 13, 2026 | Heineman Thomas Charles Officer | 12,132 | $0.83 | $10.1K | no history |
| Feb 13, 2026 | Pisano Wayne Director | 30,000 | $0.84 | $25.2K | no history |
| Feb 13, 2026 | Look Kirk Officer | 12,000 | $0.84 | $10.1K | no history |
| Jan 20, 2026 | Seizinger Bernd R. Director | 100,000 | $1.04 | $104.0K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.